NF-kappaB factor c-Rel mediates neuroprotection elicited by mGlu5 receptor agonists against amyloid beta-peptide toxicity.
about
NF-kappaB Signaling Pathways in Neurological Inflammation: A Mini ReviewNeuronal Gene Targets of NF-κB and Their Dysregulation in Alzheimer's DiseaseNF-kappaB pathway: a target for preventing beta-amyloid (Abeta)-induced neuronal damage and Abeta42 productionMinimal NF-κB activity in neuronsReduced cAMP, Akt activation and p65-c-Rel dimerization: mechanisms involved in the protective effects of mGluR3 agonists in cultured astrocytes.NF-κB in Innate Neuroprotection and Age-Related Neurodegenerative Diseases.Differential regulation of Mn-superoxide dismutase in neurons and astroglia by HIV-1 gp120: Implications for HIV-associated dementia.Human neuronal uncoupling proteins 4 and 5 (UCP4 and UCP5): structural properties, regulation, and physiological role in protection against oxidative stress and mitochondrial dysfunction.Late-onset Parkinsonism in NFκB/c-Rel-deficient miceGroup I metabotropic glutamate receptor-mediated gene transcription and implications for synaptic plasticity and diseases.NFkappaB in neurons? The uncertainty principle in neurobiologyNF-kappa B as a therapeutic target in neurodegenerative diseases.A neuronal model of Alzheimer's disease: an insight into the mechanisms of oxidative stress-mediated mitochondrial injury.Pituitary adenylate cyclase-activating polypeptide (PACAP) promotes both survival and neuritogenesis in PC12 cells through activation of nuclear factor κB (NF-κB) pathway: involvement of extracellular signal-regulated kinase (ERK), calcium, and c-RETransient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia.Roles of NF-kappaB in central nervous system damage and repair.Post-ischemic brain damage: NF-kappaB dimer heterogeneity as a molecular determinant of neuron vulnerability.NF-kappaB in the nervous system.Mitochondrial neuronal uncoupling proteins: a target for potential disease-modification in Parkinson's disease.Roles for NF-κB and gene targets of NF-κB in synaptic plasticity, memory, and navigation.Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.Anti-apoptotic therapy with a Tat fusion protein protects against excitotoxic insults in vitro and in vivo.Glucocorticoid-Induced Leucine Zipper in Central Nervous System Health and Disease.Transcriptional regulation mechanisms of hypoxia-induced neuroglobin gene expression.Identification of novel small molecule activators of nuclear factor-κB with neuroprotective action via high-throughput screening.The acetylation of RelA in Lys310 dictates the NF-κB-dependent response in post-ischemic injuryCell-penetrating interactomic inhibition of nuclear factor-kappa B in a mouse model of postoperative cognitive dysfunction.Membrane-permeable Bcl-xL prevents MPTP-induced dopaminergic neuronal loss in the substantia nigra.Nuclear factor kappa B may increase insight into the management of neuroinflammation and excitotoxicity in autism.NeuroProtective effects of adenosine receptor agonist coadministration with ascorbic acid on CA1 hippocampus in a mouse model of ischemia reperfusion injury.Impact of C-rel inhibition of cord blood-derived B-, T-, and NK cells.Nuclear factor-kappa B: Glucocorticoid-induced leucine zipper interface analogs suppress pathology in an Alzheimer's disease modelAcetylation state of RelA modulated by epigenetic drugs prolongs survival and induces a neuroprotective effect on ALS murine model
P2860
Q26770760-C6ED5286-F536-4149-B008-F21C383524D9Q28074504-23B15F3D-9F7A-4320-AE43-8369EE649117Q28196676-60AF9E89-65BC-4DDE-B00F-D927E78676CEQ28294910-5F746E7C-0494-483F-8C3B-F6FB7F73DB7BQ33968317-1A25ADE4-9EA6-4A6A-9FE0-367971F1288AQ35627153-C2A2F8A8-0E7D-4779-8BC8-C46BABBB0B57Q35956006-9658A70D-32CF-4A0C-A490-C667021799CDQ36206017-E7D08D59-9AEA-480D-98D3-E4826A9B89ADQ36218699-FCC43BA2-D7E1-4D6A-9CB3-2547150C8885Q36361892-2391F437-DBAE-40AF-A329-46E31ECA64E9Q36435841-C44A9FB1-5CDC-44A5-80C4-40FAE7FB2C54Q36709527-4230F17F-C8A4-464A-8F06-8DF724B16A3EQ36725255-A39E9FA8-348A-4250-927F-970536A813A1Q36873611-F3B91EAA-3DAD-4596-91D9-3D28B30F85ECQ36916418-C221C11D-60F6-4F9F-A489-0F9A6BAE73E7Q36977565-EB2F0DA0-D82B-46F0-941D-04D37F1AB4D9Q37352183-D19B55D1-DFFB-454C-A2FE-0C1B116701A6Q37412663-902FD1C5-0243-47A0-9F23-34F094CEDDFBQ38064965-3F27563C-8228-4D40-813B-DFE00C39D0E6Q38152296-233DD99D-6109-4933-AE1A-D35C09384C5AQ38344541-790C997C-C6EF-4007-B9AB-5DC46D19C0B0Q38844748-82A86B8C-53CA-4A0A-9623-7DBD4EDE022BQ39021109-B2F3870F-D42B-4DBB-8C26-73AA1404E72BQ39413285-BC194B3F-4708-4FEA-B825-7FAA3B7C130FQ39636333-847D26A8-085B-4677-AA26-1859503281A0Q41878080-331A006B-F0B2-4ECC-858F-5976ED082368Q42677339-CD5FE43C-35C9-4D19-8891-6C2915B51841Q46905324-CA8D3AE5-0E2F-4C98-A328-6F977C57CDB1Q50310961-7A599E3A-583E-4B5A-83CB-59BC34E64C3AQ50746084-DEFCB5E3-7046-404D-BD13-8A0DBF184F14Q51043186-E27FB2EA-AA93-4591-B852-C5229856B43FQ58574209-89EFFEBB-F367-46EB-ADE7-3E3762D0AB79Q58701384-CFF05246-DF28-4E0B-A753-261A18BC38BE
P2860
NF-kappaB factor c-Rel mediates neuroprotection elicited by mGlu5 receptor agonists against amyloid beta-peptide toxicity.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
NF-kappaB factor c-Rel mediate ...... amyloid beta-peptide toxicity.
@en
type
label
NF-kappaB factor c-Rel mediate ...... amyloid beta-peptide toxicity.
@en
prefLabel
NF-kappaB factor c-Rel mediate ...... amyloid beta-peptide toxicity.
@en
P2093
P2860
P50
P356
P1476
NF-kappaB factor c-Rel mediate ...... amyloid beta-peptide toxicity
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.CDD.4401598
P577
2005-07-01T00:00:00Z
P5875
P6179
1017389306